Dr. Emanuel Revici - the doctor who cured cancer and a whole lot of other conditions!


FOTCM Member
I just finished reading the book:

It was a great read, but I was frustrated because the author did not specify in each case what approach was taken.

The book was published awhile back, so I went on a search for more up-to-date info. I found the following:

Revici Therapy
Avatar Richard Walters13 min read

Dr. Emanuel Revici has developed an original approach to the treatment of cancer. His nontoxic chemotherapy uses lipids, lipid-based substances, and essential elements to correct an underlying imbalance in the patient’s chemistry. Lipids-organic compounds such as fatty acids and sterols-are important constituents of all living cells. They are a separate, critical system in the body’s defenses against illness, according to research conducted by Dr. Revici early in his career.

The Romanian-born physician, who practices in New York City, has applied his wide-ranging discoveries for over sixty years to the treatment of cancer as well as many other disorders, including AIDS, arthritis, Alzheimer’s disease, chronic pain, drug addiction, schizophrenia, allergies, shock, and burns. The great majority of his cancer patients are in advanced stages of the illness. Five, ten, sometimes twenty years after receiving treatment, some of these patients are in remission with no signs of active disease.

Revici, in his mid-nineties, is fiercely dedicated, still makes occasional house calls, and has patients call him at home. To critics, his approach is far too complex, too theoretical, and inconsistent in its results. Even friendly critics within the alternative health field say he cures very few cancer patients. But to admirers, he is a man who has saved the lives of cancer patients pronounced hopeless by orthodox doctors, a scientific genius who has opened up whole new vistas and whose theories and discoveries may serve as a principal basis for future medicine.

Commenting on Revici’s 1961 book, Research in Physiopathology as a Basis of Guided Chemotherapy With Special Applications to Cancer, Dr. Gerhard Schrauzer a leading authority on selenium, wrote, “I came to the conclusion that Dr. Revici is an innovative medical genius, outstanding chemist and a highly creative thinker. I also realized that few of his medical colleagues would be able to follow his train of thought and thus would be all too willing to dismiss his work.”1

Dr. Revici views health as a dynamic balance between two opposing kinds of activity that occur in all living systems. One process, the anabolic, or constructive, fosters the growth and build-up of natural patterns. The other process is catabolic, or destructive, involving the breakdown of structure, the liberation of energy, and the utilization of stored resources. According to Dr. Revici, a long-term predominance of either activity leads to abnormality and disease.

In his “guided 1ipid” therapy with cancer patients, Revici has found two basic patterns of 1ipid imbalance-one, the result of an excess of sterols, and the other, the result of an excess of fatty acids. Sterols are solid unsaturated alcohols such as cholesterol. In treating cancer, Revici first determines whether the anabolic or catabolic phase of activity is currently progressing unchecked. Then he administers lipidbased compounds to renormalize the balance between the body’s opposing forces.

Revici describes the body’s overall defense system as consisting of four successive phases. When an antigen, or foreign substance, such as a virus or microbe, enters an organism, it activates the defense system. In the first phase, the antigen is broken down by enzymes. This is followed by the lipidic phase, followed in turn by the coagulant antibody phase, and succeeded finally by a phase mediated by globulinic antibodies able to fully neutralize the antigen.

The key point about this defense system is that a new phase does not start until the previous phase has been successfully completed. At any point where the agents available are qualitatively insufficient to defend against the noxious influence, the sequence breaks down. Then the body overcompensates by manufacturing excessive amounts of the defense agents from the breakdown point, and it does not progress to the next phase. Revici found that most chronic diseases, including cancer, are characterized by such abnormal conditions. When the body’s defense is arrested in the lipidic phase, either fatty acids or sterols are produced in abnormally large quantities, leading to a variety of disorders, including cancer.

Patients diagnosed with an excess of sterols are treated with fatty acids to correct the imbalance. Conversely, patients found to have a predominance of fatty acids are treated with sterols and other agents.

This “biologically guided chemotherapy,” as Dr. Revici calls it, is highly individualized to suit each person’s specific metabolic character and condition. “There are simply no two cancers which are alike, just as no two individuals are alike,” he has said.2 The substances and dosages used are unique for each patient and can be changed if analytical tests reveal a change in the body’s balance. Through regular tests, such as the urine pH, specific gravity, surface tension, and chloride index, Dr. Revici can detect systemic changes in the body produced by lipid imbalances.

Revici’s research has demonstrated that lipids have an affinity for tumors and other abnormal tissues. Because of this, the lipids or lipid-like synthetic compounds administered to the patient, either by mouth or injection, travel directly to the tumor or lesion. Cancerous tissue is abnormally rich in free lipids, and the lipidic agents introduced into the bloodstream are readily taken up by the tumor.

Revici’s nontoxic cancer therapy has been denied both fair testing and funding in the United States, though it has been studied and put into practice in France, Italy, and Austria. A distinguished physician and research scientist who graduated first in his class at the University of Bucharest, Dr. Revici has been stereotypically portrayed by the American media as a quack who should have been put out of business a long time ago. The American Cancer Society put Revici’s therapy on its Unproven Methods blacklist in 1961, and in 1984, the State of New York tried to revoke his medical license permanently on grounds of deviation from standard medicine, negligence, incompetence, fraud, the use of unapproved experimental drugs, and similar charges. After four years of struggle, Revici triumphed in duly 1988 with a decision that placed him on probation but allows him to continue treating cancer patients.

To save his license, Revici’s patients and several medical civil-liberties groups undertook intensive lobbying at the state capitol. At the federal level, New York Congressman Guy Molinari held an all-day hearing in March 1988 to address the Revici matter and the whole field of alternative cancer therapies. Dr. Seymour Brenner, a respected radiation oncologist in private practice in New York, testified on Revici’s behalf He had investigated a number of patients in very advanced stages of cancer, incurable by orthodox means, whom Revici had put into long remissions. Dr. Brenner had an independent panel of pathologists confirm the diagnosis and stage of illness prior to each patient’s initial visit to Revici. He testified that his personal findings strongly suggest Revici has a cancer treatment deserving further study, and he proposed that such an evaluation be conducted by the FDA.

In a letter to Congressman Molinari, Brenner outlined a protocol in which a panel of doctors would monitor cancer patients placed on alternative therapies after their conditions had been deemed unamenable to the standard forms of treatment. The letter contained the detailed case histories of ten advanced cancer patients whom Revici had healed.

One patient, a forty-three-year-old man, was diagnosed with an invasive, high-grade cancer of the bladder at Memorial Sloan-Kettering Cancer Center in September 1980. “They said, ‘The only way you can be treated is if we take your bladder out and give you a colostomy on the side.’ He said no.”, The patient visited Dr. Revici in October and went on the therapy. He has had no other treatment. In 1987, he returned to Sloan-Kettering for a cystoscopy, which revealed him to be cancer-free.

Another patient, a twenty-nine-year-old woman, was operated on at Memorial Sloan-Kettering in October 1983 for a chordoma, a brain tumor. The tumor was incompletely resected, and the patient was given a course of radiation therapy. The young woman’s condition progressively worsened during the twelve months following surgery. She was seen by Dr. Revici in May 1984, at which time she was confined to a wheelchair, with limited function. Since she started the Revici program, she has had two babies and functions well. Her only problem is that she walks with a cane.

Marianne Dimetres achieved remission from preterminal uterine cancer through a combination of Revici’s nontoxic medications, wheatgrass therapy, diet, and psychological support. See her story on page 157.

Revici, who holds patents for his numerous chemical compounds, claims to have devised a novel technique to open double bonds in molecules of unsaturated fatty acids in order to incorporate different metallic elements at precise points in the molecules. The result is an entirely new series of therapeutic compounds, exceedingly low in toxicity and incorporating selenium, copper, sulfur, zinc, calcium, nickel, beryllium, mercury, lead, and other elements. In general, these compounds reportedly have a toxicity less than one-thousandth of that of the elements in the forms normally available. The technique converts toxic substances into safe anticancer agents. “Through this method, Revici has opened up an entirely new field for the therapeutic use of these elements,” according to Dr. Dwight McKee, one of Revici’s medical associates.4

Revici’s use of selenium in the treatment of cancer predates mainstream interest in this mineral by more than twenty years. Selenium is one of the major trace elements always found deficient in cancer-prone populations. Research has shown that it is of value not only in preventing cancer but also in treating it. Revici uses a special molecular form of selenium (bivalent-negative selenium) incorporated in a molecule of fatty acid. In this form, he can administer up to 1 gram of selenium per day, which corresponds to 1 million micrograms per day, reportedly with no toxic side effects. In contrast, too much selenite (hexavalent-positive selenium) has toxic effects on animals, so human intake of commercial selenite is limited to a dosage of only 100 to 150 micrograms by mouth. Dr. Revici often administers his nontoxic form of selenium by injection, usually considered to be four times more powerful than the form given orally.

Extra selenium in the diet drastically reduces the spontaneous occurrence of cancer in mice. In human populations, high selenium intake correlates with low cancer rates. In a 140-~patient study of cancer victims treated with selenium, Dr. R. Donaldson of the St. Louis Veterans’ Administration Hospital reported in 1983 that some patients deemed terminal with only weeks to live were completely free of all signs of cancer after four years; all the patients showed a reduction in tumor size and in pain.5

Dr. Revici uses the Periodic Table of Elements as one of several guides when choosing the best course of treatment for a patient. This ties in with his view that cancer is part of a hierarchical organization found throughout Nature, from the precellular level to the entire organism. All the known elements, in his view, can be classified as supporting either anabolic or catabolic activity, and each element’s biological activity correlates with its position in the Periodic Table. Revici maintains that the vertical rows in the table all share either anabolic or catabolic activity, whereas the horizontal rows indicate at which level of biological organization a particular element acts-whether at the level of a subnuclear particle (nucleoprotein), nucleus, cell, tissue, organ, or whole body. By this means, Dr. Revici determines the body level (or levels) most affected by the illness and therefore most in need of therapeutic intervention. This information is correlated with diagnostic tests indicating which imbalance is present at which level.

Harassed for decades by the American medical monopoly, Revici, ironically, had originally come to the United States seeking freedom to do his work. A scientific prodigy, he had written his first research manuscript at the age of twelve and entered the University of Bucharest at seventeen. In 1936, after serving as an assistant professor on the Faculty of Medicine, he moved with his family to Paris, where he spent three years investigating the biochemistry of cancer. When World War II erupted, the Revicis fled to Nice, where the doctor joined the French Resistance and gave medical aid to wounded Resistance fighters sought by the Nazis. His anti-fascist activities so endangered him and his wife and daughter that the leaders of the French Underground had to arrange for the family’s passage out of Europe.6 The Revicis settled m Mexico, where Dr. Revici founded the first Institute of Applied Biology, in Mexico City.

Eager to advance his research in the United States, Dr. Revici was granted three special visas through the intercession of Sumner Welles, a special aide to President Franklin D. Roosevelt.7 Revici moved to Chicago, then to New York, establishing the institute anew in Brooklyn in 1947. Today, his office is located in a two-story building in Manhattan, where he treats patients aided by a small support staff.

By 1948, Revici had begun exploring the use of selenium in treating cancer and as a means for rendering radiation less harmful. His promising findings on radiation came to the attention of United States Navy scientists testing A-bombs in the Pacific. Twice, the scientists invited him to join them in studying radiation’s harmful effects.

In 1954, Revici’s fund-raising organization financed the purchase of Beth David Hospital in Manhattan. Renamed Trafalgar Hospital, this general-care facility employing over 200 resident and visiting physicians enabled Revici, as the chief of oncology, to provide round-the-clock care for critically ill patients. Its animal research laboratories were staffed by 35 scientists and technicians, all involved in projects related to Revici’s theories and therapeutic approach. Revici served as chief of Trafalgar’s oncology department for over twenty years. The hospital dosed in 1978 due to financial difficulties.

Revici’s treatment agents were used in Belgium with favorable results by Professor Joseph Maisin, president of the International Union Against Cancer and director of the Cancer Institute of the University of Louvain. Between 1965 and his death from a car accident in 1971, Maisin corresponded with Revici to describe how he treated patients with advanced metastatic cancer who had failed conventional therapies. Maisin used several Revici preparations, at times coupled with low-dose radiation. He reported that in nine of the twelve terminal-cancer patients on the Revici medicines, significant improvements occurred, including regression of tumors, disappearance of metastases, and cessation of hemorrhage. Incredibly, paralyzed patients were able to walk again.

Dr. Revici developed successful treatments for heroin and alcohol addiction. His detoxification agent for heroin addicts, called Perse, was almost chosen over methadone as the nation’s treatment of choice. Perse, which incorporated selenium in a lipid base, physically detoxified addicts within five to eight days. At the request of Congress, Revici presented over 2,000 case histories of successful uses of this nontoxic and nonaddictive agent. The idea for Perse had arisen from Revici’s cancer practice after he observed that patients previously on addictive narcotic analgesics exhibited no withdrawal symptoms when placed on his lipid analgesics.

At a 1971 congressional subcommittee hearing that took testimony about Perse for a full day, Congressman Charles Rangel of New York said, “The results and what we witnessed with patients was so unbelievable that the doctor from Municipal Hospital has now gone back on a daily basis in order to continue with this chance to see the miraculous results that have taken place.”

Barron’s ran a full-page feature on Revici’s treatments for narcotic and alcohol addiction in 1972. Both Congress and the FDA promised Dr. Revici full support for large-scale clinical testing, signaling that Perse could be the most important breakthrough in drug treatment. Because selenium is normally toxic in high doses, Revici reformulated the medication to eliminate it. The new substance, called Bionar, worked just as well-in the same amount of time, with no withdrawal symptoms. (The selenium incorporated in Perse was a bivalent-negative form, very active and virtually nontoxic.)

The stage seemed set for a major advance in the war on drugs. But less than one month after the congressional hearing, the FDA reversed its position and recommended methadone, an addictive and toxic drug, as the treatment of choice. Why?

One possible answer is provided by Marcus Cohen, who helped coordinate the campaign to save Revici’s license. He suggests, “Hospitalization was required for treatment with Perse, and because many of the patients were poor, Medicaid was asked to pick up the tab. As in the case of most drug addicts, they presented with other conditions besides addiction which needed medical attention…. Methadone, addicting in itself, nevertheless was favored by State and City officials as a means of controlling the mostly black and Hispanic drug population…. The drug companies and health care professionals that profited from exclusive use of methadone did not welcome competition, least of all from a treatment which did not cause a lifelong dependency.”8

Dr. Revici’s nontoxic treatment for AIDS applies his findings on the antiviral and immune-enhancing properties of certain lipids. He views AIDS as a “quadruple pathological condition,” consisting of:

1. a primary viral infection, inducing

2. a deficiency in the body’s natural lipidic defense, followed by

3. secondary opportunistic infections or specific neoplasms (cancers)

due to the lack of certain lipids, resulting in

4. an exaggerated imbalance, usually catabolic.

Each of the four conditions is addressed with a specific therapeutic approach. Antiviral agents are given to inactivate, or kill, the human immunodeficiency virus (HIV). To counteract the patient’s nonspecific loss of defense against opportunistic infections, Dr. Revici administers, via injection, a group of phospholipids that he calls refractoriness lipids. These compounds appear to induce a generalized resistance (refractoriness) toward many different antigens. The doctor claims impressive results with these preparations in the clinical manifestations of AIDS and AIDS Related Complex (ARC). Antibiotics are also given to combat the secondary opportunistic infections. To redress bodily imbalances, the appropriate anticatabolic or antianabolic agents are used.

Two of Revici’s therapeutic compounds for cancer, amyl selenide and tri-thioformaldehyde (TT), tested positive in trials conducted in the late 1970s by the National Cancer Institute and Roswell Park Memorial Institute.9 Another selenium compound that Revici developed showed activity against four tumor systems in tests conducted in England. However, the dose at which antitumor activity was found was “fairly close to the toxic dose,” and further studies of the compound were recommended.

An unpublished study of the 1,047 cancer patients treated with the Revici regimen between 1946 and 1955 was made by Robert Ravich, M.D., who worked closely with Revici. Most of the patients were far advanced or terminal, and most had prior conventional treatment. Of the 1,047 cases, Ravich found that 100 had favorable response (objective and subjective); 11 had objective response only; 95 had subjective response only; 296 showed no response; and 545 had equivocal or undetermined response (380 of this last group were treated for less than three months).10

The only published clinical study of Revici’s treatment for cancer appeared in the Journal of the American Medical Association JAMA) in 1965. It was written by a panel of nine New York physicians after Revici himself requested that a scientific panel review his cancer-management program. After two years of observation, the panel concluded that the Revici therapy was “without value.” The authors reported that 22 of the 33 patients in the study died of cancer or its complications while on the Revici treatment and 4 more died after discontinuing the regimen. None of the 33 showed signs of objective tumor regression, according to the authors.

Dr. Revici wrote a detailed rebuttal in which he stated that the panel had ignored evidence indicating several tumor remissions, multiple reductions in tumor size, and relief of pain in many advanced patients. He noted that of the nine physicians on the panel, only two had actually seen the patients during the entire two-year study. He further commented that he had requested the study in the “hope that the demonstration of positive results in even a few of these advanced cases would excite sufficient interest to lead to a large-scale study of our approach…. To conclude from a limited study, such as this, that the method should be discontinued, in all cancers, is to say that since surgery and radiation have failed in these same terminal patients, these ‘recognized’ methods should also be discontinued, not only in these types of cancer but in all cancers in general.” Although Dr. Revici submitted substantiating pathological data in his lengthy rebuttal,JAMA refused to publish it.

It is now more than forty years since Revici developed his nontoxic chemotherapy. An open-minded, unbiased evaluation of it is long overdue.


1. Gerhard N. Schrauzer, Ph.D., letter to the Board of Regents, Department of Education, State of New York, 14 February 1986.
2. Barry Bryant, Cancer and Consciousness (Boston: Sigo Press, 1990), p. 147.
3. The Cancer Chronicles, vol. 2, no. 1, Summer 1990, p. 2; and Seymour Brenner, M.D., letter to Guy V. Molinari, 24 March 1988.
4. Dwight L. McKee, M.D., Emanuel Revici MD.: A Review of His Scientific Work (New York: Institute of Applied Biology, 1985), p. 14.
5. Richard A. Passwater, Cancer and Its Nutritional Therapies (New Canaan, CT: Keats Publishing, 1983), p. 149.
6. Marcus A. Cohen, “On Emanuel Revici, M.D.,” unpublished manuscript, 1988.
7. Ibid., pp. 1, 6.
8. Ibid., p. 12.
9. Ibid., pp. 4, 14.
10. Robert Ravich, “Revici Method of Cancer Control. Evaluation of 1047 Patients With Advanced Malignancies Treated From 19461955,” unpublished manuscript, undated.


Emanuel Revici, M.D.

26 East 36th Street

New York, NY 10016

Phone: 212-685-0111



FOTCM Member
I learned about Dr. Revici last year after reading a chapter about his most outstanding cases in a 1990s cancer book. From the whole book, it was among the few practitioners from way back then who was able to reverse aggressive brain cancers. His concepts are fascinating, although I was left with the impression that you have to consult a specialized practitioner, which as I understand, there are quite a few around the world.


FOTCM Member
The book certainly leaves a person confused. He talks a lot about pH balance, but then says that it can reflect a reaction to something pathological in the body, or, conversely, a persistent pH problem might lead to the pathological condition! Apparently, in order to figure it out, you have to do a whole slew of other tests and even then, it's iffy that you are going to get it right. Dr. Revici didn't always, but he was darned good. Plus, the condition can reverse and then you have to reverse the therapy!

It's all very confusing and one wonders how to reconcile it with Mark Sircus's book about Sodium Bicarbonate therapy for cancer.


Padawan Learner
William Kelly was a teacher of Nicholas Gonzalez, another alternative cancer practitioner.

I initially heard of his work in this thread: Eating for your nervous system and personality type which discusses his book Nutrition and the Autonomic nervous system which helped me to understand more about the different bodily "types" and why some people may need more/less of certain macro and micro nutrients (such as more or less meat/carbohydrates) as well as the pancreas' role in developing cancer.

Unfortunately his untimely death has been noted in this thread as part of the Holistic doctors who have died recently: Holistic Doctors being murdered?

His work is largely based around the use of pancreatic digestive enzymes and balancing the autonomic nervous system in healing the body which is interesting given Gaby's recent post regarding the autonomic nervous system: The Autonomic Nervous System and Neural Therapy as a regulation tool


FOTCM Member
Apparently, in order to figure it out, you have to do a whole slew of other tests and even then, it's iffy that you are going to get it right. Dr. Revici didn't always, but he was darned good. Plus, the condition can reverse and then you have to reverse the therapy!

It's all very confusing and one wonders how to reconcile it with Mark Sircus's book about Sodium Bicarbonate therapy for cancer.

My thoughts exactly. That is why at some point I was more worried than fascinated with Dr. Revici's research. How to reconcile the two? I don't think people had a worsening cancer from drinking sodium bicarbonate alone. At the worst, it just didn't help.


The Living Force
FOTCM Member
This sounds like something to keep an eye on:

"New treatment for killing cancer cells may have accidentally been discovered by a group of British scientists, according to reports.

Cardiff University’s research team found a T-Cell that attaches itself onto human cancers, and kills them while ignoring healthy cells. Although in its early stages of development, the treatment successfully destroys bone, lung, breast, colon, prostate, and other cancers, The Telegraph reported. Originally, researchers were only looking for immune cells that were capable of fighting bacteria, before they discovered the T-Cell virus. Their findings were made available on Monday.

“There’s a chance here to treat every patient,” Professor Andrew Sewell of Cardiff University told the BBC. “Previously nobody believed this could be possible. It raises the prospect of a ‘one-size-fits-all’ cancer treatment, a single type of T-cell that could be capable of destroying many different types of cancers across the population.”

A T-cell is a white blood cell in the immune system that fights off cancers and helps prevent the body from getting infected. Researchers note the receptors on the newly discovered T-cells may be able to locate cancers by using the molecule known as MR1. They believe this molecule could be alerting the T-cells of the infected metabolism present on cancerous cells.

“We are the first to describe a T-cell that finds MR1 in cancer cells—that hasn’t been done before, this is the first of its kind,” the studies co-author Gary Dolton said to the BBC.

In the past, researchers have gained knowledge of the human immune system through the growth of cancer immunotherapy. One of the most successful being that of CAR-T, better known as a drug made by genetically modifying an individuals T-Cell’s to destroy cancerous regions of the body, as reported by Newsweek.

“CAR-T cells have to be engineered for each patient individually, to take into account the fact that each person’s immune cells have their own molecular ‘signature’—making the therapy very expensive and laboursome,” said Astero Klampasta, a researcher at The Institute of Cancer Research in London, to Newsweek.

Experts have praised the study for its “great potential” but note that they still cannot confirm if it works for all types of cancers.

“At the moment, this is very basic research and not close to actual medicines for patients,” said Professor Daniel Davis of the University of Manchester to the BBC. “There is no question that it’s a very exciting discovery, both for advancing our basic knowledge about the immune system and for the possibility of future new medicines.” "


FOTCM Member
I finally read this book and was thoroughly impressed. I think Revici was just a great soul and genius ahead of his time who worked tirelessly to help people and who received inordinate amounts of attack to shut him down.

Despite Revici's efforts and willingness to teach other people what he learned and discovered, his research remains relatively unknown and unrecognized. He was talking about leukotrienes, inflammatory cells, way before they were described and unsurprisingly, the Nobel Prize went to someone else. He met with Einstein and debated Linus Pauling on his research, yet people hardly if ever heard of him. He left a treasure trove of research that remains untapped.

What I found fascinating is that he devised "an evolutionary" theory that made me think of intelligent design. That is, certain things are a certain way because of fundamental laws. He left behind several publications, including his 1961 textbook on natural chemotherapy which is 800 pages and available online.

I'm pretty sure Revici was into something and general medicine and science are still missing his part of the puzzle. The terminology he used might be outdated, but it could be potentially expanded with current research on virology and so forth. It's a shame he was so ostracized as he was from science in general.

This was a man with a track record of reversing the irreversible - terminal diseases. Although he was not always successful, his track record was astonishing.

Highly recommended reading for those who are interested in chemistry, medicine and healing in general.

Below some excerpts of the book:

Many different chemical reactions are occurring in the human body all the time. Different body salts combine with various compounds constantly. Proteins and amino acids also regroup constantly, and carbohydrates quickly break down into simple sugars. With each of those changes the characteristics of the new products can be quite different from the previous ones. One common characteristic for most of those reactions is their water solubility.

Revici theorized that rapid, water-soluble reactions played a much lesser role in cancer metabolism because tumors don’t change much in character from one moment to the next. He theorized that there must be a substance that would provide the stability tumors manifest. That idea of a stable, non-water soluble substance led him to look at lipids as a likely place to find some answers. He wrote, “They form a group ‘apart’ from all the water-soluble constituents, a fact which permits them to function without continuous interference from the other constituents.

As he continued his search, Revici combed the scientific literature on lipids only to find them to be a largely ignored topic to the point that even the definition of what comprised a lipid was inadequate. Striking out largely into unexplored territory, he learned through his own research that some lipids would promote an acid reaction in the urinary pH while others promoted an alkaline reaction. That finding would become one of the most important discoveries he would make in the treatment of cancer and other dualistic diseases. With that finding Revici had found a way to attack cancer, whether it exhibited an acid imbalance or an alkaline imbalance.

With this new information, Revici decided to drop placental lipids as a treatment due to their overly alkaline properties that were often difficult to reverse, and replaced them with two categories of lipids with antagonistic properties: fatty acids and sterols. Revici found acid pain patterns could be controlled with the highly unsaturated fatty acid lipids almost immediately, while the sterol lipids did the same for alkaline pain patterns. “In both cases, the effect occurred in a few minutes.” Tumor shrinkage would often follow within a matter of days or weeks.

Furthermore, his theories and applications have received recognition, if not in the United States, then from prominent international organizations. For example, the aforementioned Society for Promoting International Scientific Relations, which included 14 members who would be honored with the Nobel Prize, awarded Dr. Revici its annual medal in response to the publication of his book in 1961. The award was a confirmation of the validity of his theories by some of the most upper-echelon members of the international scientific community.

Unfortunately, his book can be difficult to read—even for physicians, many of whom are not trained in physical chemistry and atomic physics. Prior to publication of Revici’s book, his niece’s husband, then a senior editor at the University of Chicago Press, cautioned Revici that his book would have difficulty finding acceptance in the United States due to its unusual ideas and his manner of presenting them.

Any discussion of Revici’s theory of Hierarchic Organization can easily become an extremely complex affair, fit only for the rarefied air of those who are at home in a multitude of scientific disciplines. Revici supports his arguments by relying on quantum physics, electromagnetic fields and van der Waal’s cohesion forces, etc. to explain in precise, technical language why certain steps in evolution were able to take place

One of the main features of Revici’s evolutionary theory is that it proposes a layered approach to evolution. That is, simple life became more complex by slowly adding discrete layers to itself to create whole new entities. An essential factor in the ability of lower life forms to keep adding layers to itself is the series of lipid-rich compartments that were formed. Without those compartments a chemical change would be far less permanent...

To see another way in which Revici’s evolutionary theory is different from conventional wisdom, let’s consider the present widely held theory of evolution by looking at the lowly virus.

The present thinking on evolution is that one day, one of the viruses had a stress put on it that was so great that it went through a genetic mutation, making it possible for a particular virus to reproduce a different entity. From that day on, it was capable of producing a new life form. Over time these mutating occurrences resulted in the life forms of various bacteria. Thus, new life forms were made by genetically branching off from their viral ancestors. As these great stresses continued, they caused more genetic changes which, in turn, produced funguses and other life forms. Continuing over a period of eons, the process produced all the plants and animals and humans that exist today.

Revici disagrees with that scenario. While Revici’s ideas and those more generally accepted on evolution are only theories, the differences are important. Revici’s theory has enabled him to make discoveries and effective treatments for diseases which he could not have made had he held on to the more popular evolutionary theory.

Revici says that viruses came about as a result of proteins that have added a layer of nucleic acids. He views the proteins of the virus as the primary layer and the nucleic acid as the secondary layer. He points out that viruses possess an interesting feature due to the simplicity of their structure. A virus that appears to be inactive and thought to be dead can come back to life if it is given a new nucleic acid. Revici sees the virus as being at the same organizational level as the genes or possibly at the level below genes.

Let’s look at Revici’s theory of the virus’s evolutionary role in the formation of bacteria. Revici argues that a bacterium is composed of a virus that has attached itself to nucleoproteins and fatty acids.

As it turns out, each bacterium contains a protein and a nucleic acid, which are the primary and secondary parts of a virus, and an added layer of nucleoproteins combined with fatty acids. The fatty acids provide the lipid envelope that stabilizes the secondary layer of a bacterium.

According to Revici’s argument, viruses came into an environment rich in nucleoproteins and fatty acids which, under the right circumstances, allowed them to generate the new level of life forms we know as bacteria. Revici states in his book that bacterial organisms are at the same organizational level as the nuclei for reasons that are beyond the scope of this book.

This is not to say viruses don’t mutate genetically. It says that when viruses do mutate genetically, they remain viruses, and that mutation within a species is a separate branch of evolution. Through genetic mutation a number of different viruses can be produced, but a virus can never produce anything but a virus in this manner. Revici’s theory says that a virus doesn’t genetically mutate to become a different type of life form, but adds a new layer of nucleoproteins and fatty acids to do so and thus becomes a bacterium...

It is important to note, however, that without the addition of the material of the
secondary layers, not a single bacterium, fungus or other higher life form would have ever been formed, according to Revici.

There is a simple yet profound question that arises from Revici’s theory of the evolution of a virus merging with a secondary material to produce bacterial microbes. Why doesn’t the virus eat the bacterium? It turns out that the answer to that question has in it the answer to AIDS, the Ebola virus and every other viral infection that concerns modern man.

Revici reasoned that the answer had to be simple. For a bacterium to be a viable life form, despite its viral interior, it must have a natural defense that protects itself from the noxious aspects of its viral core. Without that natural defense, the virus would consume the microbe. Bacteria’s defense, Revici reasoned, had to be contained within the secondary part of the bacterial organism.

Because fatty acids and nucleoproteins are the main constituents that make up the secondary layer of bacterial microbes, it was likely that at least one of those two compounds would provide the natural defense that protects the viability of a bacterium from its own viral aspect.

Revici has solved the above question in a way that helps to confirm his evolutionary theory and has enabled him to develop a series of anti-viral drugs in the process.

In an experiment performed on rabbits, Revici tested a number of substances, including fatty acids and nucleoproteins, for their anti-viral properties. The fatty acids proved to be entirely resistant to viruses. The experiment demonstrated that the natural defense mechanism with which bacteria protect themselves comes from the fatty-acid lipids, which also happen to be one of the lipid categories Revici uses to treat cancer. Revici also found that fatty acids combined with nucleoproteins have an enhanced anti-viral activity.

In the same study, Revici determined that viruses respond to sterols and fatty alcohols in the opposite manner. Both sterols and fatty alcohols feed the virus and accelerate viral replication. According to Revici, sterols are lipids that are antagonists of fatty acids. Fatty alcohols are a category of compounds with lipidic properties that are also antagonists of fatty acids.

Further support for Revici’s Hierarchic Organization comes from the relationship of fungi to bacteria. According to Revici fungi are the next step up the evolutionary ladder from bacteria. Therefore, any fungus should have a natural defense in its secondary layer against its bacterial core. As Revici points out, many anti-bacterial agents are made from fungi. That fact lends support to the idea that each fungus has a natural defense which protects itself from the noxious effects of its bacterial core, which provides further evidence supporting Revici’s theory of a layered evolutionary world.

As you will recall, Revici had theorized that lipids are stable compounds within the body due to their lack of solubility in water. That non-solubility would be an important
feature if a substance were required to provide a constant layer of protection from an organism’s primary layer. Revici then theorized that there must be a lipidic layer at every succeeding layer of evolution. He decided to call this series of layers the “lipidic defense system” due to the apparent ability of lipids to defend a life form from the noxious organisms contained within itself. (At levels below the nuclear, the defense mechanism appears to be electromagnetic rather than lipidic, according to Revici.)

Another important aspect of his theory is the natural layer of protection each lipidic level provides, which acts as a form of insulation to separate itself from the level above it. As we’ve seen from the discussion on potassium and sodium, that insulation allows each level to act somewhat independently from the other...

With the knowledge that each layer functions somewhat independently, a whole new approach to medicine is possible.

By determining the secondary part of a particular layer, it becomes possible to intervene in an illness at whichever layer a condition is occurring, as was done with fatty acids against viruses. In his book, Revici published his findings regarding the dualistic effects of lipids applied to different layers of the evolutionary chain, including viruses, bacteria, protozoa and complex organisms. Those findings still remain a treasure yet to be discovered by researchers and the medical profession.

The examples of the virus-bacteria-fungus chain has direct application to human biology. Revici considers viruses to be “at the same level as genes or even the level below genes”. Bacteria are at the same organizational level as the nucleus, according to Revici, while single-celled organisms, such as fungi, correspond to the human cell level.

Whether or not each human cell has a virus-like entity as one of its building blocks, remains to be seen. The implications of that very real possibility are far-reaching, indeed.

If bacteria correspond to the nucleus of the human cell, it has grave implications for any anti-bacterial medicine that doesn’t take into account Revici’s theory of Hierarchic Organization and may explain, in part, why anti-bacterial medicines that are generally available have side effects...

We might define biology as living chemistry because what else is an organism but a bringing together of chemicals with life breathed into it? If biology is living chemistry, then it follows that biological functions must comply with the same principles as chemistry does. Yet the complexity of those two fields has made the search for their seminal connections an elusive quest.

Revici’s premise is that just as biology is a series of layers of chemical compounds separated by lipids, a similar pattern might be found in the layers of electrons found in chemical elements
(see appendix B).

In high school chemistry it is taught that each chemical element has one or more electron rings which surround the nucleus of the atom. The periodic chart of chemical elements reflects the number of electron rings a chemical element has by its horizontal position on the chart.

Specifically, the top horizontal row of the chart is reserved for those elements with only one ring. The second row of the chart is for elements with two electron rings. The third row of the chart is for elements with three electron rings, and so on for each of the seven rows.

With more rings an element has room for more electrons. The number of electrons an element has is determined by the number of protons the atom has in its nucleus, because it is the positive charge of the protons that holds the negative electrons in the atom’s orbit.

Revici’s premise is that each of the horizontal rows corresponds to a biological compartment. As you shall see, the elements from the lowest, or seventh horizontal row, correspond to the lowest level of biological organization while the elements from the top, or first row, correspond to the most complex level according to Revici. A comparison between potassium and sodium provides a useful example once again.

As stated earlier in this chapter, Revici found that potassium corresponded to the intracellular, or cytoplasmic, layer in biological organization. As you will also recall, potassium is much more heavily concentrated in the earth’s crust than it is in the ocean. When looking at a periodic table, one finds potassium on the fourth row from the top, the same horizontal row as calcium, iron, copper, nickel, chromium, zinc, selenium, bromine, titanium, vanadium and manganese. All of those elements are also most heavily concentrated in the earth’s crust.

Furthermore, the elements of the fourth horizontal row are found in heavier concentrations in the cytoplasm than those of the third horizontal row of the chart. Not so coincidentallly, the third horizontal row is filled with elements that are found in
heavier concentrations in the ocean than the elements in the fourth row.

A similar correspondence is seen in the human organism. The elements of the third horizontal row of the periodic table are also more concentrated in the extracellular compartment of the human organism than the elements of the fourth row of the chart.

Moving up the chart we find a similar situation. The air is almost entirely comprised of elements from the second row of the periodic chart. Revici sees a correspondence between the second row of the chart and the development of the next level of biological complexity beyond the extracellular compartment.

From those observations Revici surmised that the top horizontal row of the periodic chart could correspond to the development of the systemic level of the human organism. The second level of the periodic chart corresponds to our organs, including the lungs. The third row of elements corresponds to what Revici calls the metazoic level and includes the extracellular compartment, the blood serum and the lymph.

The fourth row corresponds to the intracellular compartment otherwise known as the cytoplasm. The fifth row of elements corresponds to the biological nuclear compartment. The sixth horizontal row of the elements corresponds to the subnuclear compartment according to Revici. The seventh row, which contains the radioactive elements, corresponds to the primitive
Revici proposes that the radioactive component of the seventh level elements might possibly be the physical source for life.

To test his hypothesis of Hierarchic Organization, Revici administered small but toxic amounts of either rubidium, potassium or sodium to mice. To track the injected material, radioactive tracers were used.

He found that rubidium, which is found on the fifth row of the periodic chart—the row Revici associates with a cell’s nucleus—typically caused an abnormal fluid space limited to the nucleus of the mice’s cells.

Potassium, an element from the fourth row of the chart—the row Revici associated with the cytoplasm—caused the same type of damage as the rubidium, but it was limited to the cytoplasm.

When the mice were injected with sodium, which is found on the third row, the row Revici associates with the extracellular area, the only damage was found in the extracellular area.

The experiment would indicate that Revici’s premise regarding a correspondence between the periodic chart and Hierarchic Organization is correct. With that correspondence he found two direct medical applications for his findings. Because the elements seem to gravitate to the level of biological organization that corresponds to its evolutionary development, Revici found that such information could be used
to better interpret the results of lab tests.

From his knowledge of lipids Revici understood that each lipidic layer had the effect of causing each biological compartment to work somewhat independently from the others. For Revici, knowing in which layer of an organism an element is most heavily concentrated has enabled him to treat various illnesses with pinpoint accuracy.

For example, Revici knew from his experience that patients who were stuck in an acid off-balance pattern often exhibited a deficiency of potassium in their blood serum. Revici’s knowledge that the blood serum wasn’t the controlling compartment for potassium in the cell led him to examine what was happening with those patients’ potassium levels at the cytoplasmic level. Through laboratory analysis he was able to differentiate whether a patient suffered from a general potassium deficiency, or if the problem resulted from excess use of potassium in the patient’s cytoplasm.

Thus, a correct understanding of the potassium readings often provided Revici with the necessary information needed to correct the root cause of the problem for the betterment of the patient. Without that knowledge a physician might incorrectly prescribe an increase in a patient’s potassium intake which would not correct the excess utilization problem and might actually intensify the patient’s condition.

A second way that Revici has been able to use his knowledge of the correspondence between the periodic table
and biology was to target certain elements to a patient’s condition
. First, Revici would determine the compartmental level of a patient’s illness, which he typically did through various tests and clinical observation.

With the proper diagnosis, including the compartmental source of the illness, he would tailor the medications to include the appropriate elements needed by the patient. In a later chapter the reader will see how large doses of individual elements such as zinc, copper, calcium, selenium or potassium are targeted to the needed compartment without causing toxicity.

Revici’s compartmental theory of Hierarchic Organization works in conjunction with another concept. As you will recall, Revici identified a condition he called dualism in a number of illnesses where either of two opposite conditions could cause the same illness. In the last chapter we saw cases of cancer accompanied by either an acid or an alkaline off-balance. In humans the alkaline cycle breaks body constituents down, while the acid cycle builds them up. Both processes are necessary for health. This process of tearing down is more commonly known as a catabolic activity while the building up process is called an anabolic activity.

As Revici further explored the periodic table of chemical elements, he noted another interesting fact. The elements in each particular vertical column were either all catabolic in their behavior or all anabolic.

For example, the first vertical column is comprised of the elements hydrogen, lithium, sodium, potassium, rubidium, cesium and francium. All of those elements are anabolic. The second vertical column contains beryllium, magnesium, calcium, strontium, barium and radium. Each of those elements in the second column are catabolic. Revici has used his knowledge of the catabolic/anabolic characteristics of the individual elements to enhance the effects of many of the medicines he has developed.

In atomic physics there is a similar dual process of anabolism and catabolism. One is a magnetic force that pulls the electrons in toward the center of the atom. The other is an outward force that pushes the electrons out. Together the two countervailing forces keep the electrons of each atom in their particular orbit.

Chemists and physicists call the two forces electromagnetic and quantum forces. With only the electromagnetic force, all the electrons would just smash together like a huge, very tightly compacted ball of aluminum foil. Revici termed that force to be an anabolic force.

On the other hand, if the only force in existence were the quantum force, electrons would fly out of their orbit away from the core of the atom. If a quantum force were allowed to act without opposition, it would cause objects to break into many smaller pieces. The quantum force is considered to be a catabolic force by Revici.
If either extreme of anabolism or catabolism were to occur unopposed in the human body on a grand scale, we would either implode or explode. Obviously that doesn’t happen.

But what if either the anabolic or the catabolic force happened on a very small scale to a relative degree? What if, in a localized area of our body, there was a preponderance of anabolic, build-up energy? Or, alternately, what if, in the same spot, we had too much catabolic, tear-apart energy? We might not be dead, but would it make us sick, and would it cause pain?

In terms of chemistry, what if the configuration of an atom or a compound became “lopsided” energetically due to a minute imbalance in the structure? Would it affect the function of the atom and those around it? If biology is living chemistry, would a slight energetic imbalance in the chemical structure of an element or compound have the potential to make a person sick?

All of the above is an oversimplification of what Revici hypothesized and, most importantly, found answers to. He then asked more questions and probed more deeply into the ramifications of Hierarchic Organization and was rewarded with some fascinating answers. Those answers have the potential to shake the foundation of what we know about nature and the world...

Revici’s insight into the building blocks of life is comparable to a house’s foundation. If one of the lipidic compartments begins to function poorly, it is relatively easy to see that any number of physical problems are likely to result. It should be equally easy to see that the repair of an improperly functioning lipid would also have the effect of correcting many different physical maladies.

Consider that without the lipid compartments there would be no single-cell animals, nor would there be any of the more complex living creatures from the invertebrates all the way up to the human form. Understanding the fundamental importance of lipids at almost every layer of life helps us to appreciate why Revici’s work has such an enormous impact on medicine.

One advantage of Revici’s principles is that once a research scientist, chemist or physician learns the theory, he or she can begin to make remarkably accurate predictions about the
effects of each element and its resulting compounds—both in the laboratory and on patients. In short, Revici’s theory is a scientist’s dream—a discovery road map.


The Living Force
FOTCM Member
I'm almost finished with the audiobook, and it made me angry how the forces in charge suppressed and smeared his work. From curing incurable cancers to nonaddictive heroin substitutes to AIDS treatments, he had range. Even when cancer was not cured, the pain was eliminated. That's potentially erasing pain for millions of people. This planet really is a factory farm of suffering.

What could he have done differently? Perhaps scientific gold stars in the form of published peer review articles might have helped. He had the retired University of Chicago famous professor working with him for free for more than a year, and that may have been the golden opportunity to collaborate and publish.


FOTCM Member
I'm almost finished with the audiobook, and it made me angry how the forces in charge suppressed and smeared his work. From curing incurable cancers to nonaddictive heroin substitutes to AIDS treatments, he had range. Even when cancer was not cured, the pain was eliminated. That's potentially erasing pain for millions of people. This planet really is a factory farm of suffering.

Yeah, it was staggering to see how they smeared and buried his research.


FOTCM Member
I'm almost finished with the audiobook, and it made me angry how the forces in charge suppressed and smeared his work. From curing incurable cancers to nonaddictive heroin substitutes to AIDS treatments, he had range. Even when cancer was not cured, the pain was eliminated. That's potentially erasing pain for millions of people. This planet really is a factory farm of suffering.

While reading the 'Doctor who cures cancer" and discovering the decades long harassment that the authorities imposed upon Revici, I remembered a similar case: Dr Burzynski and his 40-year long battle against the FDA. A documentary titled "Burzynski: The 'cancer-cure' cover-up" depicts his story:

Thinking about the similarities between Revici and Burzynski, I wonder if the efficacy of an alternative therapies is not proportional to how much it is persecuted by the authorities.


FOTCM Member
I started the Revici protocol one month ago. Having tried dozens of alternative "anti-cancer" therapies, which didn't prevent the occurrence of five brain cancers, I didn't hold my breath.

Before starting the therapy, I read "the doctor who cures cancer". From what I understand Revici identified a few dualities like catabolic vs. anabolic, anaerobic vs aerobic, acidic vs. alkaline which are the fundamental parameters that control our metabolism and disbalance in those parameters that cause diseases.

Then Revici discovered that while all the elements in one column of the Mendeleev table were exhibiting catabolic properties, all elements in the next column where exhibiting opposite properties, in that case anabolic.

Revici manage to identify the properties of number of elements as far as the catabolic vs. anabolic, anaerobic vs aerobic, acidic vs. alkalinic scales are concerned.

Then Revici embedded each active element in a lipid chain, whether in the beginning, center or end of chain. This location affects the properties of the element. In a nutshell, that is the principle, of the the Revici therapeutic agents. I also started reading the 800-page book directly written by Dr Revici and titled "Research in Physiopathology as Basis of Guided Chemotherapy: With Special Application to Cancer". The pdf is avaibale online for free. If I manage to read and understand this thick medical treaty I should able to share more about the reasoning beyond the protocol.

Although I didn't expect much out of it, those glimpses into Revici thinking picked my interest. I though that even if it doesn't solve my health issue, it might provide solutions for others. It was time to experiment. So, about two months ago, I started the diagnosis phase. Dr Lynne August, the successor of Dr Revici, based her analysis on pH tests, extensive blood work, medical history and health questionnaire.

In my case the picture was crystal clear: the anaerobic nature of the specific kind of tumor I developed, the very elevated level of cholesterol, the fatigue, the chronic headache, oversleeping, body feeling cold even when it's warm outside, etc. All the symptoms pointed to the same underlying cause: poor oxygen metabolism, in other terms anaerobic disbalance.

So I started taking elemental lipids to boost oxygen metabolism and within a few days I started noticing changes:
- Sleeping "only" 8-9 hours vs 10-11 hours a night before treatment
- No more waking up in the middle of the night and laying awake for hours
- Waking up refreshed and energized vs more tired than when I went to bed
- Being able to work 8-10 hours a day vs. 1-2 hours before treatment
- Accelerated metabolism: frequency of bowel movements, nail growth speed, hair growth speed.
- Feeling warm, resuming cold therapy quite easily vs. feeling cold in a 28°C pool (82F)!
- My veins used to be quite small and jelly-ish, now they look thicker and firmer.
- Whenever I did efforts in the Sun I got a headache, this is not the case anymore.

Another interesting thing about the Revici protocol is that it's dynamic. Regularly I update Dr August with feedbacks: extra pH tests, urine density tests, blood analysis, MRI pictures, sensations and observations, etc. and she modifies the protocol accordingly.

So those four weeks of treatment have led to unexpected results. I can only encourage you to give it a chance if you need to improve your health. For information the protocol cost me about $1,200 so far for about three months of treatment. It was worth every penny.

I believe that the Revici protocol can't absolutely prevent any cancer relapse. I see it as a therapy complementary to serious changes effected on the intellectual and emotional level. Nonetheless, the positive changes are here and there are quite impressive.


The Living Force
FOTCM Member
I can only encourage you to give it a chance if you need to improve your health. For information the protocol cost me about $1,200 so far for about three months of treatment. It was worth every penny.
Do you recommend preventative treatment with Dr. August when someone doesn't have any apparent major issues? That price is really low for 3 months of cancer treatment.
Top Bottom